Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-090862
Filing Date
2025-09-17
Accepted
2025-09-17 16:36:31
Documents
2
Period of Report
2025-09-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2526275-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2526275-1_3seq1.xml 3 1613
2 EXHIBIT 24 tm2526275d1_ex24.htm EX-24 8823
  Complete submission text file 0001104659-25-090862.txt   12106
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2505 MERIDIAN PKWY, SUITE 340 C/O CHIMERIX, INC. DURHAM NC 27713
Business Address
Richardson Linda M (Reporting) CIK: 0001595064 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-32587 | Film No.: 251320527